PLA2G12B and central nervous system cancer: PLA2G12B, a phospholipase A2 variant, is of interest, given recent evidence for the role of phospholipases in cancer and documented high expression levels in glioma, as well as its emergence as an oncogene associated with glioma progression [20,42].